We are live on
!
Find out more
CIA
Cladis Investment Advisory Portfolio holdings
AUM
$182M
1-Year Est. Return
33.3%
This Fund
S&P 500
This Quarter
Est. Return
+10.1%
1 Year Est. Return
+33.3%
3 Year Est. Return
+96.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$175M
AUM Growth
+$15.2M
(+9.5%)
Cap. Flow
+$155K
Cap. Flow
% of AUM
0.09%
Top 10 Holdings %
Top 10 Hldgs %
32.05%
Holding
158
New
11
Increased
32
Reduced
46
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
QXO
QXO Inc
QXO
|
+$1.4M |
| 2 |
Byrna Technologies
BYRN
|
+$841K |
| 3 |
United Parcel Service
UPS
|
+$756K |
| 4 |
UnitedHealth
UNH
|
+$611K |
| 5 |
Intuitive Surgical
ISRG
|
+$501K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MP Materials
MP
|
+$2.05M |
| 2 |
Snowflake
SNOW
|
+$987K |
| 3 |
Cleveland-Cliffs
CLF
|
+$371K |
| 4 |
TEM
Tempus AI
TEM
|
+$343K |
| 5 |
ONT
Onterris Inc
ONT
|
+$244K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.13% |
| 2 | Industrials | 15.27% |
| 3 | Financials | 8.29% |
| 4 | Healthcare | 7.51% |
| 5 | Communication Services | 6.89% |
Similar funds
HWM
EMB
AFS
TFP
CFG
CFG
NED
RS
Cladis Investment Advisory's Q3 2025 Portfolio in Review
As of Q3 2025, Cladis Investment Advisory held 158 positions worth $175M, up 9.5% from $160M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Cladis Investment Advisory's Q3 2025 filing shows 11 new, 32 increased, 46 reduced and 13 closed positions. Its largest new stake was Byrna Technologies: 37,900 shares worth $840K. The largest sale was MP Materials, an estimated $2.05M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Industrials and Financials.
- Cladis Investment Advisory's largest Q3 2025 buy was Byrna Technologies: 37,900 shares worth $840K.
- Cladis Investment Advisory added most to QXO Inc in Q3 2025, an estimated $1.4M increase.
- Cladis Investment Advisory's biggest Q3 2025 reduction was MP Materials, cutting an estimated $2.05M.
- Cladis Investment Advisory fully exited Catalyst Pharmaceutical in Q3 2025, selling an estimated $217K.
- Cladis Investment Advisory's ten largest holdings make up 32% of its $175M portfolio in Q3 2025.
- Cladis Investment Advisory opened 11 new positions and closed 13 in Q3 2025.
- Cladis Investment Advisory's portfolio value rose 9.5% quarter-over-quarter to $175M.
Based on Cladis Investment Advisory's 13F filing for Q3 2025, filed 13 Nov 2025.